Cullinan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CGEM Key Statistics
Stock Snapshot
Cullinan Therapeutics(CGEM) stock is priced at $12.50, giving the company a market capitalization of 738.45M. It carries a P/E multiple of -3.40.
During the trading session on 2026-01-24, Cullinan Therapeutics(CGEM) shares reached a daily high of $12.88 and a low of $12.21. At a current price of $12.50, the stock is +2.4% higher than the low and still -3.0% under the high.
Trading activity shows a volume of 729.26K, compared to an average daily volume of 664.01K.
Over the past 52 weeks, Cullinan Therapeutics(CGEM) stock has traded between a high of $13.33 and a low of $5.68.
Over the past 52 weeks, Cullinan Therapeutics(CGEM) stock has traded between a high of $13.33 and a low of $5.68.
Analyst ratings
100%
of 11 ratingsPeople also own
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.